【24h】

Estimation and predictive use of the corrected count increment-a proposed clinical guideline.

机译:估计和预测使用校正后的计数增量-拟议的临床指南。

获取原文
获取原文并翻译 | 示例
       

摘要

Background and objective. Platelets are frequently given inappropriately. The accepted indication is symptomatic thrombocytopaenia due to bone marrow failure. In contrast replacement therapy is contraindicated in immune mediated peripheral sequestration because it is almost always ineffective and also aggravates the already rapid rate of the clearance due to superimposed isoimmunisation. Furthermore circulating levels, rather than the clinical situation, customarily trigger the request and would typically be at 20x10(9)/l. Usage is under evaluated and, accordingly, current practice has been scrutinised and a guideline proposed that is applicable to user and vendor alike. Design and methodology. Prospectively a consecutive series of eligible cases were selected and, with informed consent, all relevant information recorded. Specific observations were haematologic status, quality of the product and the impact of previous exposure to blood fractions on outcome. Additionally, factors that influence responsewere documented and included disseminated intravascular coagulation, splenomegaly and concurrent use of intravenous Amphotericin B. The absolute numbers infused, the increase in peripheral value recorded and this ratio which is designated as corrected count index generated in each instance. Results. The CCI was computed for each of the 85 megaunits given to 29 individuals and subsequently estimated for the entire sample population using regression analysis. Each of the variables was used to test the hypothesis that such a figure might differ depending on patient sub-population. This approach was accurate in 60% of the time and predicates a more rational use of donor characteristics. The cardinal measurement is that supplied by the transfusion service which can be used as a basis for clinically important predictors of anticipated benefit. Conclusion. This data, in keeping with international practice, leads to the recommendation that commercial and other services routinely measure and specify absolute numbers. The clinicians, reciprocally, should always confirm this figure and then match anticipated to observed outcome. Failure to carry out these simple procedures lead to gross over utilisation of this expensive intervention, risks unnecessary sensitisation and furthers persistence with sub-optimum administration.
机译:背景和目标。经常不适当地给予血小板。公认的适应症是由于骨髓衰竭引起的症状性血小板减少症。相反,替代疗法在免疫介导的外周隔离中是禁忌的,因为它几乎总是无效的,并且由于重叠的等免疫作用,也加剧了已经迅速的清除率。此外,循环水平(而非临床情况)通常会触发请求,并且通常为20x10(9)/ l。使用情况评估不足,因此,目前的做法已经过仔细审查,并提出了适用于用户和供应商的指南。设计和方法论。预先选择了一系列连续的合格病例,并在知情同意的情况下记录了所有相关信息。具体的观察是血液学状态,产品质量以及先前接触血液成分对结局的影响。此外,已记录了影响反应的因素,包括弥散性血管内凝血,脾肿大和静脉内两性霉素B的同时使用。输注的绝对数,所记录的周围价值的增加以及该比率被指定为每次产生的校正计数指数。结果。计算给29个人的85兆单位中的每一个的CCI,然后使用回归分析估算整个样本人口。每个变量均用于检验以下假设:该数字可能因患者亚群而异。这种方法在60%的时间内都是准确的,并且可以合理地使用捐助者的特征。基本测量值是由输血服务提供的,可以用作预期收益的临床重要预测指标的基础。结论。根据国际惯例,此数据导致建议商业和其他服务例行测量并指定绝对数字。相应地,临床医生应始终确认该数字,然后将其与预期的观察结果相匹配。如果不执行这些简单的程序,则会导致过度使用这种昂贵的干预措施,从而可能导致不必要的敏感,并进一步导致次优管理的持续性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号